Biochemical markers of liver fibrosis in HCV patients

Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin

Fibroindex, a simple noninvasive test forprediction of fibrosis in patients withchronic hepatitis C virus infection

Evaluation of fibroscan as a predictor of risk of hepatocellular carcinoma in hepatitis C patients

A study of non-invasive method for liver fibrosis and prediction of hepatocellular carcinoma

Comparative study between liver biopsy versus fibroscan in chronic hepatitis C virus patients

Assessment of fibrosis biomarkers alone and incombination with tissue harmonic imaging versushistopathological fibrosis scoring in patients withchronic HCV infection and /or NASH

Role of transient elastography (fibroscan) in assessment of liver fibrosis in chronic hepatitis C patients

Correlation between degree of hepatic fibrosis by liver biopsy and insulin resistance in chronic hepatitis C

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C